Literature DB >> 35717516

The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer.

Giovanni Guarneri1,2, Diego Palumbo2,3, Nicolò Pecorelli4,5, Francesco Prato2, Chiara Gritti2, Raffaele Cerchione2, Domenico Tamburrino1, Stefano Partelli1,2, Stefano Crippa1,2, Michele Reni2,6, Francesco De Cobelli2,3, Massimo Falconi1,2.   

Abstract

INTRODUCTION: Liver steatosis (LS) has been increasingly described in preoperative imaging of patients undergoing pancreaticoduodenectomy (PD). The aim of this study was to assess the impact of preoperative LS on complications after PD and identify possible contributors to LS development in this specific cohort.
METHODS: Pancreatic head adenocarcinoma (PDAC) patients scheduled for PD, with preoperative CT-imaging available were included in the study. LS was defined as mean liver density lower than 45 Hounsfield units. Patients showing preoperative LS were matched for patient age, gender, BMI, ASA score, neoadjuvant treatment, and vascular and multivisceral resections, based on propensity scores in a 1:2 ratio to patients with no LS. The primary outcome was postoperative complication severity at 90 days as measured by the comprehensive complication index (CCI)
RESULTS: Overall, 247 patients were included in the study. Forty-three (17%) patients presented with LS at preoperative CT-scan. After matching, the LS group included 37 patients, whereas the non-LS group had 74 patients. LS patients had a higher mean (SD) CCI, 29.7 (24.5) versus 19.5 (22.5), p = 0.035, and a longer length of hospital stay, median [IQR] 12 [8-26] versus 8 [7-13] days, p = 0.006 compared with non-LS patients. On multivariate analysis, variables independently associated with CCI were: LS (16% increase, p = 0.048), male sex (19% increase, p = 0.030), ASA score ≥ 3 (26% increase, p = 0.002), fistula risk score (FRS) (28% increase for each point of FRS, p = 0.001) and vascular resection (20% increase, p = 0.019).
CONCLUSION: Preliminary evidence suggests that preoperative LS assessed by CT-scan influences complication severity in patients undergoing PD for PDAC.
© 2022. Society of Surgical Oncology.

Entities:  

Mesh:

Year:  2022        PMID: 35717516     DOI: 10.1245/s10434-022-11946-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   4.339


  45 in total

1.  Impact of circumferential resection margin distance on locoregional recurrence and survival after chemoradiotherapy in esophageal squamous cell carcinoma.

Authors:  Yin-Kai Chao; Chi-Ju Yeh; Hsien-Kun Chang; Chen-Kan Tseng; Yin-Yi Chu; Ming-Ju Hsieh; Yi-Cheng Wu; Hui-Ping Liu
Journal:  Ann Surg Oncol       Date:  2010-08-10       Impact factor: 5.344

Review 2.  Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection.

Authors:  V E de Meijer; B T Kalish; M Puder; J N M Ijzermans
Journal:  Br J Surg       Date:  2010-09       Impact factor: 6.939

3.  Comment on "The Time Has Come to Embrace Continuous Wound Infiltration via Preperitoneal Catheters as Routine Analgesic Therapy in Open Abdominal Surgery".

Authors:  Timothy H Mungroop; Sjors Klompmaker; Bart F Geerts; Denise P Veelo; Markus W Hollmann; Marc G Besselink
Journal:  Ann Surg       Date:  2019-08       Impact factor: 12.969

4.  Fatty liver: The metabolic syndrome increases major hepatectomy mortality.

Authors:  Alexander M Fagenson; Henry A Pitt; Ambria S Moten; Sunil S Karhadkar; Antonio Di Carlo; Kwan N Lau
Journal:  Surgery       Date:  2020-12-24       Impact factor: 3.982

5.  Preoperative Pancreatic Resection (PREPARE) score: a prospective multicenter-based morbidity risk score.

Authors:  Faik G Uzunoglu; Matthias Reeh; Eik Vettorazzi; Till Ruschke; Philipp Hannah; Michael F Nentwich; Yogesh K Vashist; Dean Bogoevski; Alexandra König; Monika Janot; Francesca Gavazzi; Alessandro Zerbi; Valentina Todaro; Giuseppe Malleo; Waldemar Uhl; Marco Montorsi; Claudio Bassi; Jakob R Izbicki; Maximilian Bockhorn
Journal:  Ann Surg       Date:  2014-11       Impact factor: 12.969

6.  Emergency department visits after pancreatoduodenectomy: examining a novel quality metric.

Authors:  Brendan P Lovasik; Mohammed Raheel Jajja; Salila S Hashmi; Kenneth Cardona; Maria C Russell; Shishir K Maithel; Juan M Sarmiento; Mihir M Shah; David A Kooby
Journal:  HPB (Oxford)       Date:  2019-11-14       Impact factor: 3.647

7.  Before sentinel bleeding: early prediction of postpancreatectomy hemorrhage (PPH) with a CT-based scoring system.

Authors:  Diego Palumbo; Domenico Tamburrino; Stefano Partelli; Simone Gusmini; Giorgia Guazzarotti; Roberta Cao; Stefano Crippa; Massimo Falconi; Francesco De Cobelli
Journal:  Eur Radiol       Date:  2021-03-04       Impact factor: 5.315

8.  Cardiopulmonary exercise testing for preoperative risk assessment before pancreaticoduodenectomy for cancer.

Authors:  M A Junejo; J M Mason; A J Sheen; A Bryan; J Moore; P Foster; D Atkinson; M J Parker; A K Siriwardena
Journal:  Ann Surg Oncol       Date:  2014-01-30       Impact factor: 5.344

9.  Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.

Authors:  Taylor C Brown; C Christofer Juhlin; James M Healy; Manju L Prasad; Reju Korah; Tobias Carling
Journal:  JAMA Surg       Date:  2014-11       Impact factor: 14.766

Review 10.  Chemotherapy-associated liver injury in colorectal cancer.

Authors:  Alexandra Gangi; Shelly C Lu
Journal:  Therap Adv Gastroenterol       Date:  2020-05-20       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.